Stock Earnings

Question 1

HUTCHMED (China) Ltd 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），HUTCHMED (China) Ltd 的总资产为 $0，净profit为 $37

Question 2

HCM 的关键财务比率是什么？

Accepted Answer

HUTCHMED (China) Ltd 的流动比率是 0，净利 margin 为 5.87，每股销售为 $0.72。

Question 3

HUTCHMED (China) Ltd 的收入按细分市场或地理位置如何划分？

Accepted Answer

HUTCHMED (China) Ltd largest revenue segment is Oncology/Immunology - Marketed Products, at a revenue of 2,118,769,307 in the most earnings release.For geography, China is the primary market for HUTCHMED (China) Ltd, at a revenue of 3,530,161,153.

Question 4

HUTCHMED (China) Ltd 是否盈利？

Accepted Answer

yes，根据最新的财务报表，HUTCHMED (China) Ltd 的净profit为 $37

Question 5

HUTCHMED (China) Ltd 有负债吗？

Accepted Answer

no，HUTCHMED (China) Ltd 的负债为 0

Question 6

HUTCHMED (China) Ltd 的流通股有多少？

Accepted Answer

HUTCHMED (China) Ltd 的总流通股为 0

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	602	630	837	426	356	227
Revenue Growth (YoY)	-1%	-25%	96%	20%	56.99%	11%
Cost of Revenue	336	348	384	311	258	188
Gross Profit	265	281	453	115	97	39
Selling, General & Admin	96	112	133	136	127	61
Research & Development	188	212	302	386	299	174
Operating Expenses	285	325	435	522	426	236
Other Non Operating Income (Expenses)	41	5	1	-11	-10	4
Pretax Income	535	45	105	-360	-155	-110
Income Tax Expense	67	7	4	0	11	4
Net Income	466	37	100	-360	-194	-125
Net Income Growth	-1,237%	-63%	-128%	86%	55%	18%
Shares Outstanding (Diluted)	872.56	872.82	869.19	847.14	792.68	697.93
Shares Change (YoY)	0%	0%	3%	7%	14%	5%
EPS (Diluted)	0.53	0.04	0.11	-0.42	-0.24	-0.18
EPS Growth	-1,172%	-63%	-127%	73%	36%	13%
Free Cash Flow	-59	-17	186	-305	-220	-81
Free Cash Flow Per Share	-0.06	-0.01	0.21	-0.36	-0.27	-0.11
Gross Margin	44.01%	44.6%	54.12%	26.99%	27.24%	17.18%
Operating Margin	-3.15%	-6.82%	2.15%	-95.53%	-92.13%	-86.34%
Profit Margin	77.4%	5.87%	11.94%	-84.5%	-54.49%	-55.06%
Free Cash Flow Margin	-9.8%	-2.69%	22.22%	-71.59%	-61.79%	-35.68%
EBITDA	-7	-31	26	-399	-321	-190
EBITDA Margin	-1.16%	-4.92%	3.1%	-93.66%	-90.16%	-83.7%
D&A For EBITDA	12	12	8	8	7	6
EBIT	-19	-43	18	-407	-328	-196
EBIT Margin	-3.15%	-6.82%	2.15%	-95.53%	-92.13%	-86.34%
Effective Tax Rate	12.52%	15.55%	3.8%	0%	-7.09%	-3.63%

HUTCHMED (China) Ltd (HCM) Price

HCM Stock Price Chart

HCM Income

Follow-Up Questions